Loading clinical trials...
Loading clinical trials...
The purpose of this study is to test an investigational drug, vinflunine (BMS-710485), in combination with gemcitabine in patients with Transitional Cell Carcinoma who cannot be treated with cisplatin...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Bristol-Myers Squibb
NCT06257264 · Breast Cancer, Small Cell Lung Cancer, and more
NCT07206225 · Non-muscle Invasive Bladder Cancer
NCT06661122 · Metastatic Hormone-sensitive Prostate Cancer (mHSPC), Low-volume Metastasis
NCT07174336 · Breast Neoplasms, Neoplasm Metastasis
NCT06770582 · Non-Muscle Invasive Bladder Urothelial Carcinoma, Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma, and more
University Of Alabama At Birmingham
Birmingham, Alabama
Acrc/Arizona Clinical Research Center, Inc.
Tucson, Arizona
Tower Hematology Oncology Medical Group
Beverly Hills, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions